Leaflet ATROVENT 20mcg 20mcg / dose pressurised inhalation suspension

Product code:
W07763001
Quantity:
1
Indicated for:
nasal congestion; rhinitis
Route of administration:
inhalation
Substance:
ipratropium bromide (antimuscarinic bronchodilator)
ATC
R03BB01 — Respiratory system | Other drugs for obstructive airway diseases, inhalants | Anticholinergics

Precautions:

Glaucoma warning

Use caution if you have glaucoma or increased eye pressure.

Anticholinergic effects

May cause dry mouth, constipation, urinary retention, or blurred vision.

Elderly warning

Older people may have an increased risk of side effects.

Ipratropium bromide is a bronchodilator used for the treatment of chronic obstructive pulmonary disease (COPD) and bronchial asthma. It works by blocking muscarinic receptors, relaxing airway muscles, and improving breathing.

The medication is administered as an aerosol or nebulizer solution, as directed by a doctor. It is important to follow the recommended dose to avoid side effects.

Side effects may include dry mouth, cough, throat irritation, or dizziness. In rare cases, severe allergic reactions or breathing difficulties may occur.

Ipratropium bromide is not recommended for patients with hypersensitivity to this medication or other anticholinergics.

General data about ATROVENT 20mcg 20mcg / dose

Substance:
ipratropium bromide
Date of latest medicines list:
01-07-2013
Product code:
W07763001
Concentration:
20mcg / dose
Pharmaceutical form:
pressurised inhalation suspension
Quantity:
1
Product type:
Original
Prescription status:
P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Concentrations available for ipratropium bromide

  • 20mcg/dose
  • 250mcg/2ml
  • 250mcg/ml
  • 500mcg/2ml

Combinations with other substances